中文
Products

Procalcitonin / C-reactive protein (PCT/CRP) Detection Kit

Procalcitonin / C-reactive protein (PCT/CRP) Detection Kit (Quantum Dots-Based Immunofluorescence Chromatography)

Intended Use

For the in vitro quantitative detection of Procalcitonin (PCT) and C-reactive protein (CRP) in human serum, plasma, whole blood, or capillary blood.

Procalcitonin / C-reactive protein (PCT/CRP) Detection Kit

Clinical Department

Paediatrics Department, Neonatology Department, PICU/NICU, Clinical Laboratory, Emergency Department, ICU, Infectious Diseases Department, Respiratory Medicine Department, Hematology Department, Surgery Department, Cardiology Department, etc.

Product Parameters Clinical application

[Product Name]Procalcitonin / C-reactive protein (PCT/CRP) Detection Kit

[Sample Type]Serum, plasma, whole blood, or capillary blood

[Intended Use]
For the in vitro quantitative detection of Procalcitonin (PCT) and C-reactive protein (CRP) in human serum, plasma, whole blood, or capillary blood.

[Clinical Department]
Paediatrics Department, Neonatology Department, PICU/NICU, Clinical Laboratory, Emergency Department, ICU, Infectious Diseases Department, Respiratory Medicine Department, Hematology Department, Surgery Department, Cardiology Department, etc.


Product Parameters

Item

PCT/CRP

Test Time

15min

Sample Type

Serum, plasma, whole blood, or capillary blood

Sensitivity

0.01ng/mL; 0.1mg/L

Storage Condition

4-30℃

Packing Specification

25 Tests/Kit; 50 Tests/Kit


PCT and CRP are commonly used inflammatory biomarkers in clinical practice, primarily for assessing infection type, severity, and inflammatory response status.

PCT rises rapidly within 2–3 hours following bacterial infection and peaks at 12–24 hours post-infection, with levels positively correlated to infection severity. Clinically, this biomarker is used as an adjunct for the diagnosis of bacterial infectious diseases, sepsis, and septicaemia.

CRP is one of the acute-phase reactant proteins; it begins to increase 6–8 hours after infection or tissue injury and peaks at 24–48 hours, with the magnitude of elevation positively correlated to the severity of infection or inflammation.

1. Combined PCT and CRP testing enables differentiation between bacterial infections, viral infections, and non-infectious inflammation, reducing the likelihood of missed or misdiagnoses.

2. Combined PCT and CRP testing facilitates dynamic monitoring of disease progression, allows precise assessment of infection severity, and helps determine treatment efficacy and patient prognosis.

3. Combined PCT and CRP testing can guide the rational use of antibiotics, preventing unnecessary antibiotic overuse.


微信公众平台

官网二维码